Skip to main content
Premium Trial:

Request an Annual Quote

Stuart Schwartz, Marilyn Slovak, Michael Liebman, Laura Reid, David Mahoney

Premium
Empire Genomics has named to its scientific advisory board Stuart Schwartz, Marilyn Slovak, Michael Liebman, and Laura Reid.
 
Schwartz is director of genetic diagnostic services and director of the Clinical Cytogenetics Laboratory at the University of Chicago.
 
Slovak is director of cytogenetics and professor of pathology at the City of Hope National Medical Center and is a fellow of the American Board of Medical Genetics College.
 
Liebman is executive director of the Windber Research Institute, managing director of Strategic Medicine, and chair of the Healthcare Task Force for the SMART program.
 
Reid is senior director of marketing and external scientific affairs at Expression Analysis and a member of the External RNA Controls Consortium and the ABRF Microarray Research Group.
 

 
Febit last week appointed David Mahoney as its director of global intellectual property and US legal affairs.
 

Mahoney will be based in the Heidelberg, Germany-based firm’s Boston office and will be responsible for managing US legal matters and the intellectual property portfolio of the Febit group, the company said.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.